Contrarius Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $36.8M | Buy |
783,898
+98,182
| +14% | +$4.61M | 2.1% | 17 |
|
|
2024
Q2 | $37M | Buy |
685,716
+19,716
| +3% | +$1.06M | 2.32% | 17 |
|
|
2024
Q1 | $45.4M | Buy |
666,000
+483,073
| +264% | +$32.9M | 2.62% | 15 |
|
|
2023
Q4 | $11.5M | Sell |
182,927
-37,808
| -17% | -$2.37M | 0.62% | 30 |
|
|
2023
Q3 | $10M | Sell |
220,735
-8,960
| -4% | -$407K | 0.56% | 34 |
|
|
2023
Q2 | $12.9M | Buy |
+229,695
| New | +$12.9M | 0.69% | 30 |
|